Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, MBX Biosciences Inc (NASDAQ: MBX) closed at $31.97 up 4.68% from its previous closing price of $30.54. In other words, the price has increased by $4.68 from its previous closing price. On the day, 0.82 million shares were traded. MBX stock price reached its highest trading level at $32.07 during the session, while it also had its lowest trading level at $29.98.
Ratios:
For a deeper understanding of MBX Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 32.95 and its Current Ratio is at 32.95. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on December 04, 2025, initiated with a Sell rating and assigned the stock a target price of $18.
On October 15, 2025, Truist started tracking the stock assigning a Buy rating and target price of $50.Truist initiated its Buy rating on October 15, 2025, with a $50 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 20 ’25 when Hawryluk P. Kent bought 20,000 shares for $13.64 per share. The transaction valued at 272,790 led to the insider holds 468,277 shares of the business.
Hoerter Steven L. bought 20,000 shares of MBX for $264,984 on Oct 17 ’25. The Director now owns 20,000 shares after completing the transaction at $13.25 per share. On Sep 26 ’25, another insider, Heron Patrick J, who serves as the Director of the company, bought 666,666 shares for $18.00 each. As a result, the insider paid 11,999,988 and bolstered with 5,219,440 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBX now has a Market Capitalization of 1435526656 and an Enterprise Value of 1044476608.
Stock Price History:
The Beta on a monthly basis for MBX is 0.88, which has changed by 0.40035045 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, MBX has reached a high of $34.83, while it has fallen to a 52-week low of $4.81. The 50-Day Moving Average of the stock is 46.35%, while the 200-Day Moving Average is calculated to be 130.66%.
Shares Statistics:
For the past three months, MBX has traded an average of 1.41M shares per day and 852740 over the past ten days. A total of 44.72M shares are outstanding, with a floating share count of 26.48M. Insiders hold about 41.02% of the company’s shares, while institutions hold 68.57% stake in the company. Shares short for MBX as of 1763078400 were 4629382 with a Short Ratio of 3.29, compared to 1760486400 on 3909541. Therefore, it implies a Short% of Shares Outstanding of 4629382 and a Short% of Float of 16.469998999999998.
Earnings Estimates
The dynamic stock of MBX Biosciences Inc (MBX) is currently attracting attention from 6.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.75, with high estimates of -$0.65 and low estimates of -$0.9.
Analysts are recommending an EPS of between -$2.21 and -$2.82 for the fiscal current year, implying an average EPS of -$2.56. EPS for the following year is -$3.08, with 7.0 analysts recommending between -$2.1 and -$4.58.
